Literature DB >> 23713011

The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study.

Linlea Armstrong1, Kimberly Jett, Patricia Birch, David L Kendler, Heather McKay, Erica Tsang, David A Stevenson, David A Hanley, Deetria Egeli, Melonie Burrows, J M Friedman.   

Abstract

People with neurofibromatosis 1 (NF1) have low bone mineralization, but the natural history and pathogenesis are poorly understood. We performed a sibling-matched case-control study of bone mineral status, morphology, and metabolism. Eighteen children with NF1 without focal bony lesions were compared to unaffected siblings and local population controls. Bone mineral content at the lumbar spine and proximal femur (dual energy X-ray absorptiometry (DXA)) was lower in children with NF1; this difference persisted after adjusting for height and weight. Peripheral quantitative computed tomography (pQCT) of the distal tibia showed that trabecular density was more severely compromised than cortical. Peripheral QCT-derived estimates of bone strength and resistance to bending and stress were poorer among children with NF1 although there was no difference in fracture frequencies. There were no differences in the size or shape of bones after adjusting for height. Differences in markers of bone turnover between cases and controls were in the directions predicted by animal studies, but did not reach statistical significance. Average serum calcium concentration was higher (although within the normal range) in children with NF1; serum 25-OH vitamin D, and PTH levels did not differ significantly between cases and controls. Children with NF1 were less mature (assessed by pubertal stage) than unaffected siblings or population controls. Children with NF1 have a generalized difference of bone metabolism that predominantly affects trabecular bone. Effects of decreased neurofibromin on bone turnover, calcium homeostasis, and pubertal development may contribute to the differences in bone mineral content observed among people with NF1.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23713011     DOI: 10.1002/ajmg.a.36001

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Are Children Suffering From Congenital Pseudarthrosis of the Tibia Associated With Decreased Bone Strength?

Authors:  Ge Yang; Siyu Xu; Haibo Mei; Guanghui Zhu; Yaoxi Liu; Qian Tan; Hui Yu
Journal:  Front Pediatr       Date:  2022-05-09       Impact factor: 3.569

Review 2.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.

Authors:  Harleen Chohan; Mitra Esfandiarei; Darian Arman; Catherine D Van Raamsdonk; Cornelis van Breemen; Jan M Friedman; Kimberly A Jett
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

Review 4.  The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.

Authors:  Amish Chinoy; Grace R Vassallo; Emma Burkitt Wright; Judith Eelloo; Siobhan West; Eileen Hupton; Paula Galloway; Amy Pilkington; Raja Padidela; M Zulf Mughal
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-03-01       Impact factor: 1.864

5.  Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity.

Authors:  Ursula Pia Ferrara; Cristina Tortora; Carmen Rosano; Antonia Assunto; Alessandro Rossi; Stefano Pagano; Mariateresa Falco; Chiara Simeoli; Rosario Ferrigno; Alessandra D'Amico; Dario Di Salvio; Giuliana Cangemi; Rosario Pivonello; Pietro Strisciuglio; Daniela Melis
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

Review 6.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.